Im Cannabis Corp
$ 1.38
-3.50%
29 Dec - close price
- Market Cap 7,502,900 USD
- Current Price $ 1.38
- High / Low $ 1.44 / 1.33
- Stock P/E N/A
- Book Value 0.55
- EPS -0.50
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.07 %
- ROE -1.20 %
- 52 Week High 7.12
- 52 Week Low 0.93
About
Im Cannabis Corp. (IMCC) is a prominent Israeli cannabis company based in Tel Aviv-Yafo, specializing in the cultivation, distribution, and marketing of high-quality cannabis products for both medical and recreational markets. The company has established a strong operational framework and innovative cultivation practices, allowing it to effectively scale its presence in both domestic and international markets. With a commitment to compliance with regulatory standards and a focus on premium product offerings, IM Cannabis is strategically positioned to capitalize on growth opportunities in the rapidly evolving global cannabis landscape.
Analyst Target Price
$8.22
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-13 | 2025-08-12 | 2025-05-06 | 2025-03-31 | 2024-11-14 | 2024-08-14 | 2024-05-08 | 2024-03-28 | 2023-11-13 | 2023-08-14 | 2023-05-15 | 2023-03-29 |
| Reported EPS | -0.75 | -0.09 | -0.2343 | -0.22 | -0.41 | -0.23 | -0.42 | -0.18 | -0.16 | -0.26 | 0.03 | -1.32 |
| Estimated EPS | None | None | None | -0.54 | -0.96 | -1.17 | -0.2 | -0.12 | -0.21 | -0.07 | -0.26 | -0.28 |
| Surprise | 0 | 0 | 0 | 0.32 | 0.55 | 0.94 | -0.22 | -0.06 | 0.05 | -0.19 | 0.29 | -1.04 |
| Surprise Percentage | None% | None% | None% | 59.2593% | 57.2917% | 80.3419% | -110% | -50% | 23.8095% | -271.4286% | 111.5385% | -371.4286% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: IMCC
2025-12-18 07:09:39
IM Cannabis Corp. (NASDAQ:IMCC) has seen a 40% share price surge, but its low Price-to-Sales (P/S) ratio of 0.2x, compared to an industry average of 4.1x, suggests caution. The low P/S is likely due to the company's recent lacklustre revenue growth, which significantly lags the industry's expected 25% growth. Shareholders are accepting the low P/S, indicating an expectation that future revenue will not offer pleasant surprises.
2025-12-17 08:08:46
Shares of IM Cannabis Corp. (NASDAQ: IMCC) have recently surged by 40%, yet its current price-to-sales (P/S) ratio of 0.2x, significantly lower than the industry average, suggests caution. This low P/S is attributed to the company's pedestrian financial performance, including non-existent revenue growth recently and inconsistent growth over the past three years, contrasting sharply with the broader Pharmaceuticals industry's expected 25% growth. Despite the recent stock price increase, the company's fundamentals indicate that its P/S ratio is justified by its underperformance relative to peers and a lack of positive surprises in future revenue.
2025-12-16 07:09:57
IM Cannabis Corp. has appointed Asi Levi as its new chief financial officer, effective immediately, following the resignation of Uri Birenberg for personal reasons. Levi brings over 15 years of experience in finance and controlling roles, including prior CFO positions, specializing in fundraising, financial planning, budgeting, and cash flow management. This leadership change ensures continuity in financial oversight and is reflected in the company's SEC filings.
2025-12-15 14:09:08
IM Cannabis has appointed Asi Levi, CPA, as its new Chief Financial Officer, succeeding Uri Birenberg, who resigned for personal reasons. Mr. Levi brings over 15 years of experience in finance and controlling roles, including previous CFO positions at Water Ways Technologies Inc. and DekelOil CI. He is experienced in financial planning, budgeting, cash flow management, and fundraising, ensuring compliance with international financial reporting standards.
2025-12-13 09:08:33
IM Cannabis Corp. (Nasdaq: IMCC) has appointed Asi Levi, CPA, as its new Chief Financial Officer, effective immediately. Mr. Levi brings over 15 years of finance experience, having previously served as CFO for other companies and as Controller for SciSparc Ltd. and A2Z Cust2Mate Solutions Corp. He replaces Uri Birenberg and will be responsible for financial planning, budgeting, cash flow management, and fundraising efforts.
2025-12-13 08:09:08
IM Cannabis Corp. (Nasdaq:IMCC) has appointed Asi Levi, CPA, as its new Chief Financial Officer, effective immediately. Levi brings over 15 years of finance experience and will be crucial in managing the medical cannabis company's financial challenges, including a high debt-to-equity ratio and cash burn. The appointment follows ongoing changes within the company, including a recent announcement of a non-binding term sheet to acquire a 60% equity interest in a quantum computing bio data company.
